Composition
- Active ingredients
- AZACITIDINE 100MG/VIAL
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- AZACITIDINE 100MG/VIAL · PowderANDA207234-001 · Prescription
- AZACITIDINE 100MG/VIAL · PowderANDA207475-001 · Prescription
- AZACITIDINE 100MG/VIAL · PowderANDA201537-001 · Prescription
- AZACITIDINE 100MG/VIAL · PowderANDA215765-001 · Prescription
- AZACITIDINE 100MG/VIAL · PowderANDA215905-001 · Prescription
- AZACITIDINE 100MG/VIAL · PowderANDA207518-001 · Prescription
- AZACITIDINE 100MG/VIAL · PowderANDA215066-001 · Prescription
- AZACITIDINE 100MG/VIAL · PowderANDA217453-001 · Prescription
- AZACITIDINE 100MG/VIAL · PowderANDA212580-001 · Prescription
- AZACITIDINE 100MG/VIAL · PowderNDA208216-001 · Prescription
- AZACITIDINE 100MG/VIAL · PowderThis page
- AZACITIDINE 100MG/VIAL · PowderANDA211549-001 · Discontinued
- AZACITIDINE 100MG/VIAL · PowderANDA209337-001 · Prescription
At a glance
- Brand name
- Azacitidine
- Route
- Intravenous, Subcutaneous
- Dosage form
- Powder
- Applicant
- Cipla
- Status
- Prescription
- FDA approval
- 4 May 2018
- Application
- ANDA209540-001